Psyence Biomedical Ltd.
Market Cap
$49.26K
P/E Ratio
-0.01
EPS
$-389.98
Dividend Yield
0.00%
52-Week Range
$1.92 — $468.36
Volume
14.30K
Avg Volume
219.18K
Beta
0.36
P/E (TTM)
-0.01
Forward P/E
—
PEG Ratio
-0.06
P/S (TTM)
0.00
P/B (TTM)
0.31
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.12%
ROA (TTM)
-0.05%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.00
Current Ratio
8.09
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-4.53%
EPS Growth (5Y)
-2.72%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$4.86
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
19.02K
Float
19.02K
Free Float %
100.00%
Sector
Healthcare
Industry
Biotechnology
Country
CA
Exchange
NASDAQ
IPO Date
2021-12-10
Employees
12
CEO
Jody Aufrichtig
Index Membership
—
Website
https://www.psyencebiomed.com
Psyence Biomedical Ltd. (PBM) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $49.26K, a P/E ratio of -0.01, PBM is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PBM against other stocks using dozens of fundamental and technical filters.
Psyence Biomedical Ltd. (PBM) has a trailing twelve-month (TTM) P/E ratio of -0.01. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Psyence Biomedical Ltd. (PBM) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Psyence Biomedical Ltd. (PBM) has a market capitalization of $49,259, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.